Dr Tara Sutherland

Location: Room 309, Ashworth Laboratories

Phone: 0131 651 3630

Email: tara.sutherland@ed.ac.uk

Website: http://zeldia.cap.ed.ac.uk/allenlab/people/sutherland.htm

CV

Publications

Sutherland TE, Andersen OA, Betou M, Eggleston IM, Maizels RM, van Aalten D, Allen JE.

Analyzing airway inflammation with chemical biology: dissection of acidic mammalian chitinase function with a selective drug-like inhibitor. Chem Biol. 2011 May 27;18(5):569-79. doi: 10.1016/j.chembiol.2011.02.017.
Allen JE, Bischof RJ, Sucie Chang HY, Hirota JA, Hirst SJ, Inman MD, Mitzner W, Sutherland TE.
Animal models of airway inflammation and airway smooth muscle remodelling in asthma. Pulm Pharmacol Ther. 2009 Oct;22(5):455-65. Epub 2009 Apr 23. Review.
Sutherland TE, Maizels RM, Allen JE.
Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clin Exp Allergy. 2009 Jul;39(7):943-55. Epub 2009 Apr 17. Review.
Sutherland TE, M Schuliga, RL Anderson, RA Hughes, J Ziogas and AG Stewart. 
2-Methoxyestradiol - a unique blend of activities generates a new class of anti-tumour/anti-inflammatory agents. (2007) Drug Discovery Today.  Invited Review
Langenbach SY, Wheaton BJ, Fernandes DJ, Jones C, Sutherland TE, Wraith BC, Harris T, Schuliga M, McLean C, Stewart AG .
Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice. (2007) Can J Physiol Pharm
Sutherland TE, Schuliga M, Harris T, Eckhardt BL, Anderson RL, Quan L and Stewart AG
2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer. (2005) Clin Can Res. 11(5):1722-32.
Stewart AG, Sutherland TE, Schuliga M, Harris T, Quan L, McAllister D, Pool B, Eckhardt B, Anderson RL
The potential and suitability of 2-methoxyestradiol in cancer therapy: Author Reply (2005) Clin Can Res 11(16): 6094-5